Lifestyle Remodeling in Subjective Memory Complaint (SMC): Brain Imaging and Blood Biochemistry Study
1 other identifier
interventional
50
1 country
1
Brief Summary
The specific study aims:
- 1.To investigate whether the brain function is affected by the past life experiences, such as lifestyle and physiology-related factors in SMC.
- 2.To examine whether the lifestyle remodeling could improve SMC's cognitive function and modulate the reactivity of inflammatory factors, leading to significantly slow down the disease progression to MCI or dementia.
- 3.To investigate the lasting duration of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2019
CompletedFirst Posted
Study publicly available on registry
November 14, 2019
CompletedStudy Start
First participant enrolled
November 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedNovember 14, 2023
November 1, 2023
3.3 years
September 19, 2019
November 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Changes in Electroencephalogram (EEG) performance.
The amplitude, latency of MMN (mismatch negativity), N2, and the P3 components will be used to evaluate the memory and inhibitory control ability. Other EEG time-frequency analysis will be used to examine the changes of different frequency bands, such as theta, alpha, beta, and gamma.
baseline, post-treatment (6 months), follow-up (12 months)
Concentration change from baseline in the blood biochemical indices. (Total Tau, Aβ1-40, Aβ1-42, IL-1b, TNF-a, IL-6, TGF-b, BDNF, insulin, and ApoE4)
Blood samples will use an enzyme-linked immunosorbent assay (ELISA) to assay the concentrations of Tau, Beta Amyloid (Aβ)1-40, Aβ1-42, interleukin-1β (IL-1β), tumor necrosis factor (TNF)-⍺, Interleukin-6 (IL-6), transforming growth factor (TGF)-β, brain-derived neurotrophic factor (BDNF), insulin, etc. The apolipoprotein E4 (ApoE4) genotype will also be evaluated.
baseline, post-treatment (6 months), follow-up (12 months)
Change score of the Chinese version Verbal Learning Test (CVVLT).
A nine-item of CVVLT (total recall, delayed recall) will be applied to measure the participant's memory ability, with a higher score indicating better performance.
baseline, post-treatment (6 months), follow-up (12 months)
Change score of the WMS-III logical memory test part A.
WMS-III logical memory test part A (immediate recall, delayed recall) will be applied to measure the participant's memory ability. The maximum score is 25 for each recall trial, with a higher score indicating better performance.
baseline, post-treatment (6 months), follow-up (12 months)
Change score of the Taylor Complex Figure Test (TCFT).
TCFT (immediate recall, delayed recall) will be applied to measure the participant's memory ability. The maximum score is 36 for each recall trial, with a higher score indicating better performance.
baseline, post-treatment (6 months), follow-up (12 months)
Change score of the Digit Span Backward Test.
The Digit Span Backwards Task will be applied to measure the participant's working memory ability. A higher score indicating better performance.
baseline, post-treatment (6 months), follow-up (12 months)
Secondary Outcomes (8)
Subjective memory complaint survey.
baseline, post-treatment (6 months), follow-up (12 months)
Change scores of EuroQol-5 Dimension (EQ-5D).
baseline, post-treatment (6 months), follow-up (12 months)
Lifestyle activities survey.
baseline, post-treatment (6 months), follow-up (12 months)
Physiological parameter (Blood pressure and blood glucose) survey.
baseline, post-treatment (6 months), follow-up (12 months)
Change score of the Cognitive Abilities Screening Instrument (CASI).
baseline, post-treatment (6 months), follow-up (12 months)
- +3 more secondary outcomes
Study Arms (2)
Lifestyle remodeling
EXPERIMENTALDoes Comparator: regular treatment
ACTIVE COMPARATORInterventions
Participants will be received 2 phases of intervention of lifestyle remodeling, 3 months for each phase, which contained cognitive stimulating activities and physical activities.
Participants in this group would be treated as usual, which contained the healthy education.
Eligibility Criteria
You may qualify if:
- Age over 50 years old.
- Diagnosed with subjective memory complaint (SMC) and with lower cognitive activities and physical activities.
- Voluntary to sign the Informed Consent Form.
You may not qualify if:
- Participants or first-degree relatives diagnosed with mental diseases.
- Participants have history of severe neurological diseases or brain injury led to loss of consciousness.
- Participants have diagnosis of cardiovascular disease.
- Participants have History of alcohol, Nicotine, or substance dependence.
- Participants suffer from visual, hearing degradation (including Hearing aid user).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Veterans General Hospital
Taipei, Beitou District, 11217, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pei-Ning Wang, M.D.
Taipei Veterans General Hospital, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2019
First Posted
November 14, 2019
Study Start
November 19, 2019
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
November 14, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share